Adjuvant and neoadjuvant treatment of breast cancer

被引：24

作者：

Gianni, L ^{[1
]}

Valagussa, P ^{[1
]}

Zambetti, M ^{[1
]}

Moliterni, A ^{[1
]}

Capri, G ^{[1
]}

Bonadonna, G ^{[1
]}

机构：

[1] Ist Nazl Tumori, I-20133 Milan, Italy

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 01期

关键词：

D O I：

10.1053/sonc.2001.20747

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：13 / 29

页数：17

共 60 条

[21]

DIMITROV N, 1994, P AN M AM SOC CLIN, V13, P64

[22] 2 MONTHS OF DOXORUBICIN-CYCLOPHOSPHAMIDE WITH AND WITHOUT INTERVAL REINDUCTION THERAPY COMPARED WITH 6 MONTHS OF CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN POSITIVE-NODE BREAST-CANCER PATIENTS WITH TAMOXIFEN-NONRESPONSIVE TUMORS - RESULTS FROM THE NATIONAL SURGICAL ADJUVANT BREAST AND BOWEL PROJECT B-15 [J].

FISHER, B ;

BROWN, AM ;

DIMITROV, NV ;

POISSON, R ;

REDMOND, C ;

MARGOLESE, RG ;

BOWMAN, D ;

WOLMARK, N ;

WICKERHAM, DL ;

KARDINAL, CG ;

SHIBATA, H ;

PATERSON, AHG ;

SUTHERLAND, CM ;

ROBERT, NJ ;

AGER, PJ ;

LEVY, L ;

WOLTER, J ;

WOZNIAK, T ;

FISHER, ER ;

DEUTSCH, M .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (09) :1483-1496

[23] Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer [J].

Fisher, B ;

Dignam, J ;

Wolmark, N ;

DeCillis, A ;

Emir, B ;

Wickerham, DL ;

Bryant, J ;

Dimitrov, NV ;

Abramson, N ;

Atkins, JN ;

Shibata, H ;

Deschenes, L ;

Margolese, RG .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (22) :1673-1682

[24] Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-18 [J].

Fisher, B ;

Brown, A ;

Mamounas, E ;

Wieand, S ;

Robidoux, A ;

Margolese, RG ;

Cruz, AB ;

Fisher, ER ;

Wickerham, DL ;

Wolmark, N ;

DeCillis, A ;

Hoehn, JL ;

Lees, AW ;

Dimitrov, NV .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (07) :2483-2493

[25]

FISHER B, 1983, CANCER RES, V43, P1488

[26] Effect of preoperative chemotherapy on the outcome of women with operable breast cancer [J].

Fisher, B ;

Bryant, J ;

Wolmark, N ;

Mamounas, E ;

Brown, A ;

Fisher, ER ;

Wickerham, DL ;

Begovic, M ;

DeCillis, A ;

Robidoux, A ;

Margolese, RG ;

Cruz, AB ;

Hoehn, JL ;

Lees, AW ;

Dimitrov, NV ;

Bear, HD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2672-2685

[27]

Fisher B, 1996, SEMIN ONCOL, V23, P414

[28] 1-PHENYLALANINE MUSTARD (L-PAM) IN MANAGEMENT OF PRIMARY BREAST-CANCER - REPORT OF EARLY FINDINGS [J].

FISHER, B ;

CARBONE, P ;

ECONOMOU, SG ;

FRELICK, R ;

GLASS, A ;

LERNER, H ;

REDMOND, C ;

ZELEN, M ;

BAND, P ;

KATRYCH, DL ;

WOLMARK, N ;

FISHER, ER .

NEW ENGLAND JOURNAL OF MEDICINE, 1975, 292 (03) :117-122

[29] Efficacy, toxicity, and applicability of high-dose sequential chemotherapy as adjuvant treatment in operable breast cancer with 10 or more involved axillary nodes: Five-year results [J].

Gianni, AM ;

Siena, S ;

Bregni, M ;

DiNicola, M ;

Orefice, S ;

Cusumano, F ;

Salvadori, B ;

Luini, A ;

Greco, M ;

Zucali, R ;

Rilke, F ;

Zambetti, M ;

Valagussa, P ;

Bonadonna, G .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2312-2321

[30] RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR REDUCES HEMATOLOGIC TOXICITY AND WIDENS CLINICAL APPLICABILITY OF HIGH-DOSE CYCLOPHOSPHAMIDE TREATMENT IN BREAST-CANCER AND NON-HODGKINS-LYMPHOMA [J].

GIANNI, AM ;

BREGNI, M ;

SIENA, S ;

ORAZI, A ;

STERN, AC ;

GANDOLA, L ;

BONADONNA, G .

JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (05) :768-778

← 1 2 3 4 5 6 →